- Zepp Health press release ( NYSE: ZEPP ): Q2 Non-GAAP EPADS of -$0.23.
- Revenue of $165.5M (-39.6% Y/Y).
- Total units shipped in the second quarter 2022 decreased by 45.2% year-over-year to 6.3M, compared with 11.5M in the second quarter of 2021.
-
For the third quarter of 2022, the management of the company currently expects: Net revenues to be between RMB1.2 billion and RMB1.5 billion, compared with RMB1.61 billion in the third quarter of 2021 vs. estimated growth of 23.50% Y/Y.
For further details see:
Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M